Company Listing
Novexel

Novexel discovered and developed novel anti-bacterials and anti-fungals. Formed as a spin-out of Aventis Pharma, a subsidiary of Sanofi-Aventis, it inherited an advanced portfolio of anti-infective programmes and intellectual property. The company was acquired by AstraZeneca for up to $505 million in March 2010.

BACK
Location
Paris, France

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Novexel discovered and developed novel anti-bacterials and anti-fungals. Formed as a spin-out of Aventis Pharma, a subsidiary of Sanofi-Aventis, it inherited an advanced portfolio of anti-infective programmes and intellectual property. The company was acquired by AstraZeneca for up to $505 million in March 2010.

Location
Paris, France
BACK
 
Copyright Abingworth 2017